RMgmDB - Rodent Malaria genetically modified Parasites

Back to search results

Summary

RMgm-4158
Malaria parasiteP. berghei
Genotype
MutatedGene model (rodent): PBANKA_0615200; Gene model (P.falciparum): PF3D7_0717500; Gene product: calcium-dependent protein kinase 4 (CDPK4)
Details mutation: myristoylated glycine 2 was replaced by an alanine residue preventing myristoylation of CDPK4
TaggedGene model (rodent): PBANKA_0615200; Gene model (P.falciparum): PF3D7_0717500; Gene product: calcium-dependent protein kinase 4 (CDPK4)
Name tag: c-myc
Phenotype Gametocyte/Gamete;
Last modified: 26 May 2017, 14:48
  *RMgm-4158
Successful modificationThe parasite was generated by the genetic modification
The mutant contains the following genetic modification(s) Gene mutation, Gene tagging
Reference (PubMed-PMID number) Reference 1 (PMID number) : 28481199
MR4 number
Parent parasite used to introduce the genetic modification
Rodent Malaria ParasiteP. berghei
Parent strain/lineP. berghei ANKA
Name parent line/clone RMgm-4155
Other information parent lineA drug selectable marker free P. berghei (ANKA 2.34) mutant that lakcs the cdpk4 gene.
The mutant parasite was generated by
Name PI/ResearcherFang H, Brochet M
Name Group/DepartmentDepartment of Microbiology and Molecular Medicine
Name InstituteUniversity of Geneva
CityGeneva
CountrySwitzerland
Name of the mutant parasite
RMgm numberRMgm-4158
Principal nameCDPK4(G2A)-2xmyc
Alternative name
Standardized name
Is the mutant parasite cloned after genetic modificationYes
Phenotype
Asexual blood stageNot different from wild type
Gametocyte/GameteNo exflagellation (male gamete formation). Reduced DNA replication during male gamete formation (mainly blocked at 1N).
Normal mitotoic spindle formation in microgametocytes at 10 min. after activation. Strongly reduced axoneme formation in microgametocytes at 10 min. after activation.
Fertilization and ookineteNot different from wild type
OocystNot tested
SporozoiteNot tested
Liver stageNot tested
Additional remarks phenotype

Mutant/mutation
The mutant expresses a mutated form of CDPK4, CDPK4G2A (and is drug-selectable marker free). In the mutated form the myristoylated glycine 2 was replaced by an alanine residue preventing myristoylation of CDPK4. In addition, the mutated CDPK4 is C-terminal tagged with 2xmyc

Protein (function)
CDPK4 belongs to an expanded family of Ca2+ dependent protein kinases (CDPKs). CDPKs combine an amino-terminal serine/threonine kinase domain and a carboxy-terminal calmodulin-like domain, composed of four EF hands, in the same molecule. In plants, CDPKs translate Ca2+ signals generated by external stimuli into cellular responses, thereby regulating cell division and differentiation, the development of tolerance to stress stimuli and the specific defense responses to pathogens.

CDPK4 plays a role in male gamete formation after activation of male gametes. It plays a role in male gametocytes axoneme formation, formation of mitotic spindles and DNA synthesis. Evidence has been presented for an additional role in sporozoites: reduced invasion of hepatocytes (RMgm-1510).  See PF3D7_0717500 for other CDPK4 mutants

Phenotype
CDPK4 plays a role in male gamete formation after activation of male gametes. No exflagellation occurs in male gametocytes lacking expression of CDPK4.

The mutant expressing the mutated CDPK4G2A form showed the following phenotype:
No exflagellation (male gamete formation). Reduced DNA replication during male gamete formation (mainly blocked at 1N). Normal mitotoic spindle formation in microgametocytes at 10 min. after activation. Strongly reduced axoneme formation in microgametocytes at 10 min. after activation.

CDPK4 has previously been shown to be myristoylated in P. falciparum. In the mutated form the myristoylated glycine 2 was replaced by an alanine residue preventing myristoylation of CDPK4.

Additional information
 

Other mutants
See PF3D7_0717500 for other CDPK4 mutants

 


  Mutated: Mutant parasite with a mutated gene
Details of the target gene
Gene Model of Rodent Parasite PBANKA_0615200
Gene Model P. falciparum ortholog PF3D7_0717500
Gene productcalcium-dependent protein kinase 4
Gene product: Alternative nameCDPK4
Details of the genetic modification
Short description of the mutationmyristoylated glycine 2 was replaced by an alanine residue preventing myristoylation of CDPK4
Inducable system usedNo
Short description of the conditional mutagenesisNot available
Additional remarks inducable system
Type of plasmid/construct(Linear) plasmid double cross-over
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid
Selectable marker used to select the mutant parasitehdhfr
Promoter of the selectable markereef1a
Selection (positive) procedurepyrimethamine
Selection (negative) procedureNo
Additional remarks genetic modification
Additional remarks selection procedure
Primer information: Primers used for amplification of the target sequences  Click to view information
Primer information: Primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Sequence Primer 3
Additional information primer 3
Sequence Primer 4
Additional information primer 4
Sequence Primer 5
Additional information primer 5
Sequence Primer 6
Additional information primer 6

  Tagged: Mutant parasite with a tagged gene
Details of the target gene
Gene Model of Rodent Parasite PBANKA_0615200
Gene Model P. falciparum ortholog PF3D7_0717500
Gene productcalcium-dependent protein kinase 4
Gene product: Alternative nameCDPK4
Details of the genetic modification
Name of the tagc-myc
Details of taggingC-terminal
Additional remarks: taggingThe mutated form of CDPK4 is tagged with 2xmyc
Commercial source of tag-antibodies
Type of plasmid/construct(Linear) plasmid double cross-over
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid
Selectable marker used to select the mutant parasitehdhfr
Promoter of the selectable markereef1a
Selection (positive) procedurepyrimethamine
Selection (negative) procedureNo
Additional remarks genetic modification
Additional remarks selection procedure
Primer information: Primers used for amplification of the target sequences  Click to view information
Primer information: Primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Sequence Primer 3
Additional information primer 3
Sequence Primer 4
Additional information primer 4
Sequence Primer 5
Additional information primer 5
Sequence Primer 6
Additional information primer 6